Remove 2009 Remove Clinical Trials Remove Collective Remove Legalization
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

This article provides an overview of the current state of legality of common psychedelic substances, and some of the potential therapeutic uses to which psychedelics may be applied. Collectively, private investors have poured billions of dollars into these companies, with more money coming from non-profit organizations. 10; 312.80-88;

Law 105
article thumbnail

Here’s what you need to know about cannabis research

The Cannigma

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways. Related Stories.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

It became illegal in the US in 2009. Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine.

History 119
article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

Cannabis that is high in CBD but extremely low in THC was made legal at the end of 2018. And at last, in February 2009 a dual peak on a testing graph appeared, indicating the presence of CBD. “I By the summer of 2009, the lab had identified five strains with significant CBD and THC. And because of public demand, the F.D.A.

CBD 40
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Firstly, we contextualise cannabis in terms of its historical usage, its legal status, and research relating to knowledge, attitudes, and usage. Elsewhere, cannabis has become legal completely in the case of Uruguay and Canada, and partially in other countries. Legalisation occurred in Australia in 2016.